Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS
IST:GENIL.E

Watchlist Manager
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS Logo
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS
IST:GENIL.E
Watchlist
Price: 139.1 TRY -1.97% Market Closed
Market Cap: ₺41.7B

Operating Margin

7.4%
Current
Declining
by 1.9%
vs 3-y average of 9.2%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
7.4%
=
Operating Income
₺1.4B
/
Revenue
₺18.6B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
7.4%
=
Operating Income
₺1.4B
/
Revenue
₺18.6B

Peer Comparison

Country Company Market Cap Operating
Margin
TR
Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS
IST:GENIL.E
41.7B TRY
Loading...
US
Eli Lilly and Co
NYSE:LLY
1T USD
Loading...
UK
Dechra Pharmaceuticals PLC
F:1PK
5.1B EUR
Loading...
US
Johnson & Johnson
NYSE:JNJ
529.7B USD
Loading...
CH
Roche Holding AG
SIX:ROG
275.3B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
210.3B GBP
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.8T DKK
Loading...
CH
Novartis AG
SIX:NOVN
221.9B CHF
Loading...
US
Merck & Co Inc
NYSE:MRK
269.1B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
145.8B USD
Loading...

Market Distribution

In line with most companies in Turkey
Percentile
52nd
Based on 567 companies
52nd percentile
7.4%
Low
-16 384.1% — 1%
Typical Range
1% — 15.5%
High
15.5% — 944%
Distribution Statistics
Turkey
Min -16 384.1%
30th Percentile 1%
Median 6.4%
70th Percentile 15.5%
Max 944%

Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS
Glance View

Market Cap
41.7B TRY
Industry
Pharmaceuticals

Gen Ilaç ve Saglik Ürünleri Sanayi ve Ticaret AS operates as a supplier of orphan drugs. The firm operates in the fields of manufacturing all kinds of pharmaceuticals for human use and health products, trading, import and export. Gen Ilac manufactures products used in the treatment of rare diseases and disorders in neurology, endocrinology, nephrology, oncology, hematology and pediatric branches. The firm has approximately 500 employees working in its production facilities on a closed area of 15,000 square meters, established on an area of approximately 43,000 square meters in Ankara ASO 2nd and 3rd Organized Industrial Zone. Entity has 5 offices abroad: Germany, Russia, Kazakhstan, Uzbekistan and Azerbaijan.

GENIL.E Intrinsic Value
80.63 TRY
Overvaluation 42%
Intrinsic Value
Price
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
7.4%
=
Operating Income
₺1.4B
/
Revenue
₺18.6B
What is Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS's current Operating Margin?

The current Operating Margin for Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS is 7.4%, which is below its 3-year median of 9.2%.

How has Operating Margin changed over time?

Over the last 3 years, Gen Ilac ve Saglik Urunleri Sanayi ve Ticaret AS’s Operating Margin has decreased from 11.8% to 7.4%. During this period, it reached a low of 6.5% on Jun 30, 2024 and a high of 14.4% on Mar 31, 2023.

Back to Top